home / stock / ikt / ikt news


IKT News and Press, Inhibikase Therapeutics Inc. From 03/16/23

Stock Information

Company Name: Inhibikase Therapeutics Inc.
Stock Symbol: IKT
Market: NASDAQ
Website: inhibikase.com

Menu

IKT IKT Quote IKT Short IKT News IKT Articles IKT Message Board
Get IKT Alerts

News, Short Squeeze, Breakout and More Instantly...

IKT - Penny Stocks To Buy? 4 To Watch Now After Big News

2023-03-16 09:33:00 ET When searching for penny stocks to buy or penny stocks to watch, it’s good to focus on catalysts. Typically valued under $5 per share, these stocks generally attract small and new investors. Even with the glitz and glamour that comes with massive breakouts,...

IKT - Inhibikase Therapeutics to Host Virtual R&D Event on March 22, 2023

Inhibikase Therapeutics to Host Virtual R&D Event on March 22, 2023 Inhibikase Therapeutics to Host Virtual R&D Event on March 22, 2023 PR Newswire BOSTON and ATLANTA , March 16, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT...

IKT - Inhibikase jumps 35% as FDA lifts full clinical hold on lead candidate

2023-03-08 09:07:24 ET Nano-cap biotech Inhibikase Therapeutics ( NASDAQ: IKT ) added ~35% pre-market Wednesday after announcing that the FDA lifted the full clinical hold on its lead candidate IkT-148009 targeted at neurological disorder multiple system atrophy (MSA). ...

IKT - Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Multiple System Atrophy

Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Multiple System Atrophy PR Newswire - Advancing model studies of IkT-148009 in MSA; early data has shown a substantial neuroprotective benefit in response to c-Abl inhibition by IkT-148009...

IKT - Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit

Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit PR Newswire BOSTON and ATLANTA , Feb. 15, 2023 ...

IKT - Inhibikase Therapeutics Announces Closing of $10 Million Concurrent Registered Direct Offering and Private Placement Priced At a Premium to Market Under Nasdaq Rules

Inhibikase Therapeutics Announces Closing of $10 Million Concurrent Registered Direct Offering and Private Placement Priced At a Premium to Market Under Nasdaq Rules PR Newswire BOSTON and ATLANTA , Jan. 27, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. ...

IKT - Why Is Chevron (CVX) Stock Up Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Jeff Whyte / Shutterstock.com Chevron (NYSE: CVX ) stock is on the rise Thursday following a new share buyback program and dividend for investors. That new share buyback program has a total value of $75 b...

IKT - LUV Stock Alert: Southwest Reports $800 Million Loss During Holiday Mishap

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Carlos E. Santa Maria / Shutterstock.com Southwest Airlines (NYSE: LUV ) stock is falling on Thursday following the release of its latest earnings report. The big news hitting LUV stock today is an $800 m...

IKT - Why Is Inhibikase Therapeutics (IKT) Stock Down 11% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Inhibikase Therapeutics (NASDAQ: IKT ) stock is falling on Thursday after the company announced a registered direct offering and private placement . Starting with the registered direct offeri...

IKT - Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules

Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules PR Newswire BOSTON and ATLANTA , Jan. 25, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IK...

Previous 10 Next 10